|
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Abstract number: P1911
Messmore1,2 HL, Adess1,2 M, Fabbrini2 N, Choudhury1,2 A, Bhoopalam1,2 N, Diaz1 M, Iqbal1 A, Balbale2 S, Love2 B, Zarr2 C, Schlimm2 S, Bird2 ML
1,2 1,2 11Loyola University Stritch School of Medicine, Maywood, Illinois, USA 22Hines VA Hospital, Hines, Illinois, USA
A 71 year old female with dementia (ischemic strokes in the past), no history of overt bleeding, a history of abnormal coagulation tests for over 10 years, iron deficiency anemia (on oral aspirin chronically), diabetes mellitus (adult onset), and no other significant problems was found to have a markedly prolonged prothrombin time (PT) with a normal activated partial thromboplastin time (APTT). Coagulation testing revealed the following results: PT: 110 seconds, 80.3 seconds, 77.1 seconds (Ref Range 9.011.8 seconds) APTT: 29.5 seconds, 29 seconds, 29 seconds (Ref Range 2234 seconds) Thrombin Time: 17.9 seconds (Ref Range 1221 seconds) Fibrinogen: 598 mg/dL (Ref Range 200400 mg/dL) Inhibitor Screen: Positive (Immediate Acting) Lupus Anticoagulant Screening Profile: Negative Factor Assays V, VII, VIII, IX, X, II were all normal ANA, anti-DS DNA, Immunoglobulin Assays and Blood Viscosity were normal Additional studies revealed a prothrombin time with rabbit brain thromboplastin (Dade® Thromboplastin C Plus®) of 13.2 seconds as compared with a prothrombin time of 79.4 seconds with recombinant human tissue factor thromboplastin (Dade® Innovin®). The patient's serum was inhibitory to Innovin® but not to Thromboplastin C Plus® as determined by mixing her serum 1 : 1 with normal human plasma. The inhibition was immediate. Recombinant Factor VIIa (NovoSeven®) added to her plasma partially corrected the abnormal prothrombin time when supplemented at therapeutic concentrations in vitro. Conclusion: Inhibitor of human tissue factor by both patient serum and plasma.
|